Background Pulmonary embolism (PE) is seen in high frequency in hospital-treated patients
with Covid-19. We present a case of suspected Covid-19 with long-term dyspnea and …

Background The thrombogenic potential of Covid-19 is increasingly recognised. We aim to
assess the characteristics of COVID-19 patients diagnosed with pulmonary embolism (PE) …

Aims While pulmonary embolism (PE) appears to be a major issue in COVID-19, data
remain sparse. We aimed to describe the risk factors and baseline characteristics of patients …

Recent reports have suggested an increased risk of pulmonary embolism (PE) related to
COVID-19. The aim of this cohort study is to compare the incidence of PE during a 3-year …

Abstract Introduction Coronavirus disease 2019 (COVID-19) has been associated with
cardiovascular complications and coagulation disorders. Previous studies reported …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease that primarily affects
the respiratory system, but it may cause cardiovascular complications such as …

Background COVID-19 is still a global challenge in regard for management and therapy.
Pulmonary embolism (PE) seems to have a higher prevalence in COVID-19 instead of non …

Aims We investigated the incidence, risk factors, clinical characteristics, and outcomes of
pulmonary embolism (PE) in patients with COVID-19 attending emergency departments …

BACKGROUND Emerging reports indicate a high incidence of venous thromboembolism in
patients hospitalised for SARS-CoV-2 pneumonia during the spring 2020 pandemic. The …

There remains a high risk of thrombosis in patients affected by the SARS-CoV-2 virus and
recent reports have shown pulmonary embolism (PE) as a cause of sudden death in these …